INVESTIGATIONS Haemoglobin was 63 % (100 % 14 6 g.), P.C.V. 30%, M.C.H.C. 31 %, W.B.C. 3,000/ c.mm., platelets, 210,000/c.mm., reticulocytes, 17%; the film showed normochromic, normocytic red cells with some polychromasia, a slight neutropenia, and plentiful platelets of normal appearance. The bone marrow was hypercellular with stainable iron absent; erythropoiesis was hyperplastic and normoblastic and plasma cells were present in normal numbers.
The Coombs test, the L.E. cell test and the latex L.E. test were negative; Heinz bodies were absent; serum albumin and globulin concentrations were normal with a normal electrophoretic pattern, and macroglobulins and cryoglobulins could not be demonstrated. Serum iron was 30/pg./100ml., I.B.C.,T. 295/,ug./100ml., leucocyte ascorbic acid, 26 ,ug. per 108 white cells (normal range, 23-53 ,ug . per 108 white cells). Estimation of blood urea and serum electrolyte concentrations and liver function tests, including bromsulphthalein excretion, gave results in the normal range. The Wassermann reaction was negative and a chest radiograph and barium meal examination revealed no abnormality. No correction was obtained by the addition of protamine in amounts of 0 5, 2-0, and 5-0 mg. per ml.
The results of the thromboplastin generation test are presented in Table I and show a defect in the patient's absorbed plasma, a defect which was not demonstrated in the patient's serum.
The thromboplastin generation test was modified to include various combinations of normal, haemophilic and patient's plasma, and patient's serum. The results are shown in Table II . The addition of patient's plasma at saline dilutions of either 1 in 5 or 1 in 10 in an otherwise normal generating system produced impairment of thromboplastin formation, whereas incorporation of patient's serum produced only minimal alterations. Mutual correction of the defect was not produced when a mixture of patient's and haemophilic plasma was used.
When patient's plasma was used as substrate in the thromboplastin generation test with a normal generation mixture, a normal result was obtained ( 'Each generation tube contained 0-2 ml. of normal serum (1/10) and 0-2 ml. normal platelet suspension in addition to the above. Fractionation of the patient's plasma with 18 % sodium sulphate was carried out and the supernatant and redissolved precipitate were incorporated separately in an A.H.G. assay system. The supernatant lacking in y globulin ( Fig. 1) , produced inhibition of A.H.G. but the redissolved precipitate did not, demonstrating that the circulating anticoagulant was not a y globulin. The supernatant was not dialysed to remove sodium sulphate, but the addition of 18% sodium sulphate to an assay system did not result in inhibition of A.H.G.
Using immunofluorescent methods, the presence of antinuclear factor and antibodies to gastric mucosa could not be demonstrated but moderately strong fluorescence was obtained with thyroid, indicating the presence of antibody to the thyroid epithelial 'microsomal' antigen; the tanned red cell agglutination test for antithyroglobulin (Anderson, 1964) A course of prednisolone, begun nine days after admission, coincided with a rapid fall in the whole blood clotting time and rise in A.H.G. concentration to 18%. However, following a reduction in steroid dosage to 10 mg. daily the level of A.H.G. fell to 8-9% (Fig. 2) .
Antihaemophilic globulin assays performed on mixtures of 3 parts of patient's plasma and 7 parts of normal plasma (A.H.G. 100%) after 19 and 32 days' steroid therapy gave results of 80 % and 75 % respectively, indicating the disappearance of inhibitor activity, Normal Generation Mixture plus G. group.bmj.com on June 8, 2017 -Published by http://jcp.bmj.com/ Downloaded from although the A.H.G. concentration in the patient's plasma remained low (Fig. 2) . These assays were performed without prior incubation at 37°C. as it had been previously established that this did not increase the degree of inhibition.
A maintenance dose of 10 mg. of prednisolone daily was continued, and six months later the A.H.G. concentration was 105% with a whole blood clotting time of 9 min. DISCUSSION Circulating anticoagulants inhibiting A.H.G. have been observed in four groups of patients. In classical haemophiliacs Lawrence and Craddock, 1947; Frommeyer, Epstein, and Taylor, 1950; Hougie and Fearnley, 1954; Lewis, Ferguson, and Arends, 1956; Verstraete and Vandenbroucke, 1956; Biggs and Bidwell, 1959; Margolius et. al., 1961) ; in women who developed a haemophilia-like condition in association with pregnancy and parturition (Bruno and Brody, 1954; O'Brien, 1954; Nilsson, Skanse, and Gydell, 1958; Margolius et al., 1961; Walpot, 1964) ; in association with a variety of disorders, e.g., rheumatoid arthritis (Collins and Ferriman, 1952; Spaet and Kinsell, 1954; Favre-Gilly, Thouverez, and TourniaireLamicq, 1958; Margolius et al., 1961; Lee and Raccuglia, 1962; Sise et al., 1962) , rheumatic heart disease (Hardisty, 1954) , penicillin sensitivity (Nussey and Dawson, 1957; Margolius et al., 1961) , rheumatic fever with idiopathic thrombocytopenic purpura (Barkhan 1952) , hyperglobulinaemia (Nilsson and Wenckert, 1953), regional enteritis (Ellis, Handley, and Taylor, 1959) , 'collagen disease' (Margolius et al., 1961) , and syphilis with tuberculous lymphadenopathy (Lozner, Jolliffe, and Taylor, 1940) ; and unassociated with any demonstrable underlying disease or condition (Collins, 1953; Hougie, 1953; Goldstein, 1954; Evans, 1955; Lewis et al., 1956; Verstraete and Vandenbroucke 1956;  Biggs and Bidwell, 1959; Henderson, 1959; Margolius et al., 1961; Breckenridge and Ratnoff, 1962; Ehrenworth, 1963 Frommeyer et al., 1950; Hougie and Fearnley, 1954; Verstraete and Vandenbroucke, 1956 ) and in the idiopathic group (Hougie, 1953; Verstraete and Vandenbroucke, 1956 ); other authors have reported negative precipitin reactions in cases from all four groups (Conley, Ratnoff, Ellicott, and Hartmann, 1950; Hardisty, 1954; Biggs and Bidwell, 1959; Breckenridge and Ratnoff, 1962) . The association of circulating anticoagulants of this type with the various disorders of the immunological mechanisms in the third group has been invoked as further support for the theory that these anticoagulants represent an immune phenomenon (Collins and Ferriman, 1952; Spaet and Kinsell, 1954; Nussey and Dawson, 1957; Favre-Gilly et al., 1958) .
However, Biggs and Bidwell (1959) were unable to demonstrate antibody-like activity to A.H.G. in the plasma or serum of patients in the haemophilic and idiopathic groups, using tanned red cell and Coombs inhibition techniques. They also considered that the increase in inhibitory activity over quite long periods of time of exposure of A.H.G. to inhibitor in their cases would suggest that the reaction is not antigen-antibody in type. Breckenridge and Ratnoff (1962) suggested that in their case, one of the 'idiopathic' variety, the inhibitor was enzymatic in nature.
In most of the previous cases where activity has been sought in the serum it has been clearly present, and, indeed, Hougie and Fearnley's (1954) test for 'antithromboplastinogens' depends on this.
In the present case, the inhibitor is not a y globulin and it has not been possible, by the techniques employed, to demonstrate antibody activity to A.H.G. in the patient's plasma.
Apart from antibody to thyroid tissue, no evidence of an autoimmune disorder has been discovered; the presence of this antibody is of doubtful significance as antithyroid antibodies can be demonstrated in 16-8 % of apparently normal females over the age of 50 years (Goudie, Anderson, and Gray, 1959 
